P01.005 The impact of thrombocytopenia from concomitant and adjuvant temozolomide in patients with glioblastoma

BACKGROUND: Temozolomide (TMZ) administered daily with radiation therapy for six weeks, followed by adjuvant TMZ for six months is standard therapy for patients (pts) with newly diagnosed glioblastoma (GBM). Thrombocytopenia (TBP) usually appears in 10 % of patients and is responsible for treatment...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Nivet, A, Schernberg, A, Louvel, G, Dumont, S, Ammary, S, Rehalia-Blanchard, A, Clavère, P, Parker, F, Pallud, J, Dhermain, F
Format: Artigo
Language:Inglês
Published: Oxford University Press 2018
Subjects:
Poster Presentations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144430/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.047
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items